Prevention and One Health Implications of Leptospirosis

Despite advances in diagnosis and treatment, leptospirosis continues to pose a significant threat due to its zoonotic potential and environmental persistence. Prevention strategies must therefore address both individual patient protection and broader public health considerations. 

Vaccination: The Primary Preventive Tool 

Vaccination remains the most effective method for preventing clinical disease in dogs. Currently available vaccines target multiple serovars, with quadrivalent vaccines providing broader coverage against commonly circulating strains. 

Studies have shown that these vaccines offer over 80% protection against clinical disease and renal carrier status^1,2. However, immunity is serogroup-specific, meaning protection may not extend to all circulating strains. 

Annual vaccination is recommended for all dogs, regardless of lifestyle, as exposure risk cannot be reliably predicted. Puppies should receive an initial series followed by regular boosters. 

Limitations of Vaccination 

While effective, vaccines do not provide complete protection. Breakthrough infections can occur, particularly in areas where circulating serovars differ from those included in vaccines. 

This reinforces the need for clinicians to continue considering leptospirosis in vaccinated dogs presenting with compatible signs. 

Environmental and Lifestyle Management 

Reducing exposure to leptospires is an essential component of prevention. This includes minimizing contact with standing water, controlling rodent populations, and limiting interaction with wildlife or livestock. 

Urban environments are not exempt. Poor sanitation, rodent infestations, and communal dog settings such as kennels or daycare facilities can all increase risk¹. 

Zoonotic Risk and Veterinary Responsibility 

Leptospirosis is a classic One Health disease, affecting both animals and humans. Although transmission from dogs to humans is considered relatively low, it can occur through contact with infected urine, particularly in high-risk situations. 

Veterinary professionals play a critical role in minimizing this risk by¹: 

• Identifying suspected cases early  

• Implementing appropriate infection control measures  

• Educating pet owners about precautions  

Standard hygiene practices, including the use of protective equipment and proper disinfection, are highly effective in reducing transmission risk. 

Managing Risk in Clinical and Home Settings 

In veterinary clinics, suspected cases should be handled with care, particularly during the first 48 hours of treatment. Minimizing exposure to urine and maintaining strict hygiene protocols significantly reduces risk. 

At home, pet owners should be advised to avoid direct contact with urine and maintain cleanliness until antimicrobial therapy has been established. Education is key to preventing unnecessary fear while ensuring appropriate precautions. 

The Bigger Picture: One Health Approach 

Leptospirosis highlights the interconnectedness of human, animal, and environmental health. Rodents remain the primary reservoir, and environmental factors such as rainfall, flooding, and sanitation play a major role in disease transmission. 

A One Health approach, integrating veterinary care, public health awareness, and environmental management, is essential for long-term control. 

Clinical Takeaway 

Prevention of leptospirosis goes beyond vaccination. It requires a comprehensive strategy that includes immunization, environmental management, and awareness of zoonotic risk. 

For veterinarians, the goal is not only to protect individual patients but also to contribute to broader disease control through education and responsible clinical practice. 

Reference 

1. Sykes JE, Francey T, Schuller S, Stoddard RA, Cowgill LD, Moore GE. Updated ACVIM consensus statement on leptospirosis in dogs. Journal of veterinary internal medicine. 2023 Nov;37(6):1966-82. https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jvim.16903?utm_source=consensus 
2. Esteves SB, Santos CM, Salgado FF, Goncales AP, Guilloux AG, Martins CM, Hagiwara MK, Miotto BA. Efficacy of commercially available vaccines against canine leptospirosis: A systematic review and meta-analysis. Vaccine. 2022 Mar 15;40(12):1722-40. https://doi.org/10.1016/j.vaccine.2022.02.021